PALB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.307600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.666800E-01
Normal-vs-Stage2
8.407600E-01
Normal-vs-Stage3
4.021600E-01
Normal-vs-Stage4
6.132200E-01
Stage1-vs-Stage2
5.224000E-01
Stage1-vs-Stage3
4.351200E-01
Stage1-vs-Stage4
3.888200E-01
Stage2-vs-Stage3
1.533370E-01
Stage2-vs-Stage4
6.333400E-01
Stage3-vs-Stage4
3.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.760600E-01
Normal-vs-AfricanAmerican
8.580200E-01
Normal-vs-Asian
8.917600E-01
Caucasian-vs-AfricanAmerican
8.211600E-01
Caucasian-vs-Asian
8.135200E-01
AfricanAmerican-vs-Asian
9.705200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.840800E-01
Normal-vs-Female
8.939200E-01
Male-vs-Female
6.577200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.775400E-01
Normal-vs-Age(41-60Yrs)
7.554600E-01
Normal-vs-Age(61-80Yrs)
9.633200E-01
Normal-vs-Age(81-100Yrs)
8.514800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.573800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.253800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.537400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.043600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.384200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.923600E-01
Normal-vs-Daily Drinker
9.421000E-01
Normal-vs-Weekly Drinker
8.927000E-01
Normal-vs-Occasional Drinker
7.650800E-01
Normal-vs-Social Drinker
7.671000E-01
Non Drinker-vs-Daily Drinker
9.438800E-01
Non Drinker-vs-Weekly Drinker
6.009600E-01
Non Drinker-vs-Occasional Drinker
3.626600E-01
Non Drinker-vs-Social Drinker
4.803400E-01
Daily Drinker-vs-Weekly Drinker
7.108800E-01
Daily Drinker-vs-Occasional Drinker
5.001000E-01
Daily Drinker-vs-Social Drinker
5.875200E-01
Weekly Drinker-vs-Occasional Drinker
8.280800E-01
Weekly Drinker-vs-Social Drinker
9.862200E-01
Occasional Drinker-vs-Social Drinker
7.785600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.008600E-01
Normal-vs-Grade 2
7.415700E-02
Normal-vs-Grade 3
6.451600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.550200E-04
Grade 1-vs-Grade 3
6.24809999999476E-05
Grade 1-vs-Grade 4
4.008600E-01
Grade 2-vs-Grade 3
1.336240E-01
Grade 2-vs-Grade 4
7.415700E-02
Grade 3-vs-Grade 4
6.451600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.635400E-01
Normal-vs-NonDiabetic
9.059600E-01
Diabetic-vs-NonDiabetic
1.657220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.894400E-01
Normal-vs-NoPancreatitis
9.709000E-01
Pancreatitis-vs-NoPancreatitis
7.596800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.621000E-01
Normal-vs-N1
8.470000E-01
N0-vs-N1
4.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.616400E-01
Normal-vs-TP53-NonMutant
9.279000E-01
TP53-Mutant-vs-TP53-NonMutant
1.360040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
